• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢泊肟在年轻和老年志愿者单次给药后的药代动力学

Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses.

作者信息

Tremblay D, Dupront A, Ho C, Coussediere D, Lenfant B

机构信息

Roussel Uclaf, Direction Recherches Santé, Romainville, France.

出版信息

J Antimicrob Chemother. 1990 Dec;26 Suppl E:21-8. doi: 10.1093/jac/26.suppl_e.21.

DOI:10.1093/jac/26.suppl_e.21
PMID:2292526
Abstract

Three pharmacokinetic studies involving single oral doses of cefpodoxime proxetil in healthy volunteers are reported. The first study was to determine the absolute bioavailability of cefpodoxime, the second was to study the relationship between the oral dose of cefpodoxime proxetil and pharmacokinetic parameters of cefpodoxime, and the third was to compare the pharmacokinetics of cefpodoxime in healthy young and elderly volunteers. Half the dose of cefpodoxime orally administered as cefpodoxime proxetil in tablet form reaches the systemic circulation, while 80% of the cefpodoxime absorbed is excreted unchanged in urine. The volume of distribution is large (32.3 l). The pharmacokinetics of cefpodoxime were linear in young and elderly subjects after 100 and 200 mg oral doses, which are those used therapeutically. The Cmax was about 1.4 mg/l (after 100 mg) and 2.6 mg/l (after 200 mg). Deviation from linearity appeared at 400 mg and the effect was confirmed at 800 mg. The differences between young and elderly subjects were negligible, with the exception of the half-life which increased by only 14%, from 2.67 to 3 h. Dosage adjustment is therefore not necessary in the elderly.

摘要

本文报道了三项在健康志愿者中进行的关于单次口服头孢泊肟酯的药代动力学研究。第一项研究旨在测定头孢泊肟的绝对生物利用度,第二项研究是探究头孢泊肟酯口服剂量与头孢泊肟药代动力学参数之间的关系,第三项研究则是比较健康年轻志愿者和老年志愿者体内头孢泊肟的药代动力学情况。以片剂形式口服给药的头孢泊肟酯中,有一半剂量的头孢泊肟能够进入体循环,而吸收的头孢泊肟中有80%以原形经尿液排出。分布容积较大(32.3升)。在年轻和老年受试者中,口服100毫克和200毫克(治疗常用剂量)的头孢泊肟后,其药代动力学呈线性。Cmax分别约为1.4毫克/升(100毫克后)和2.6毫克/升(200毫克后)。在400毫克时出现非线性偏差,并在800毫克时得到证实。除半衰期仅增加14%(从2.67小时增至3小时)外,年轻和老年受试者之间的差异可忽略不计。因此,老年人无需调整剂量。

相似文献

1
Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses.头孢泊肟在年轻和老年志愿者单次给药后的药代动力学
J Antimicrob Chemother. 1990 Dec;26 Suppl E:21-8. doi: 10.1093/jac/26.suppl_e.21.
2
Pharmacokinetic and tolerance studies of cefpodoxime after single- and multiple-dose oral administration of cefpodoxime proxetil.头孢泊肟酯单剂量及多剂量口服给药后头孢泊肟的药代动力学和耐受性研究。
J Clin Pharmacol. 1991 Dec;31(12):1137-45. doi: 10.1002/j.1552-4604.1991.tb03686.x.
3
Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine.头孢泊肟酯与乙酰半胱氨酸联合给药时的生物利用度。
Arzneimittelforschung. 1996 Apr;46(4):435-8.
4
Multiple dose pharmacokinetics of cefpodoxime in young adult and elderly patients.头孢泊肟在青年和老年患者中的多剂量药代动力学
J Antimicrob Chemother. 1990 Dec;26 Suppl E:29-34. doi: 10.1093/jac/26.suppl_e.29.
5
Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist.头孢泊肟酯的药代动力学及其与抗酸剂和H2受体拮抗剂的相互作用。
Antimicrob Agents Chemother. 1992 Apr;36(4):796-800. doi: 10.1128/AAC.36.4.796.
6
A review of the pharmacokinetics of cefpodoxime proxetil.头孢泊肟酯的药代动力学综述。
Drugs. 1991;42 Suppl 3:13-21. doi: 10.2165/00003495-199100423-00005.
7
Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil.单次口服头孢泊肟酯后血浆和扁桃体组织中头孢泊肟的浓度。
J Antimicrob Chemother. 1990 Dec;26 Suppl E:47-51. doi: 10.1093/jac/26.suppl_e.47.
8
Pharmacokinetics of cefpodoxime proxetil in healthy young and elderly volunteers.
J Clin Pharmacol. 1994 Jul;34(7):774-81. doi: 10.1002/j.1552-4604.1994.tb02039.x.
9
The bioavailability of cefpodoxime proxetil tablets relative to an oral solution.头孢泊肟酯片相对于口服溶液的生物利用度。
Biopharm Drug Dispos. 1995 May;16(4):295-302. doi: 10.1002/bdd.2510160405.
10
The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.静脉注射头孢泊肟钠与口服头孢泊肟酯在比格犬体内的血浆药代动力学比较
J Vet Pharmacol Ther. 2007 Aug;30(4):320-6. doi: 10.1111/j.1365-2885.2007.00873.x.

引用本文的文献

1
Cefazolin as a predictor of urinary cephalosporin activity in indicated Enterobacterales.头孢唑林对有指征的肠杆菌科细菌尿液头孢菌素活性的预测作用。
J Clin Microbiol. 2024 Apr 10;62(4):e0078821. doi: 10.1128/jcm.00788-21. Epub 2024 Mar 8.
2
Review of antimicrobial use and considerations in the elderly population.老年人抗菌药物使用的评价及相关考虑因素。
Clin Interv Aging. 2018 Apr 17;13:657-667. doi: 10.2147/CIA.S133640. eCollection 2018.
3
Detection of favorable oral cephalosporin-clavulanate interactions by in vitro disk approximation susceptibility testing of extended-spectrum-Beta-lactamase-producing members of the enterobacteriaceae.
通过对产超广谱β-内酰胺酶的肠杆菌科成员进行体外磁盘近似药敏试验来检测有利的口腔头孢菌素-克拉维酸相互作用。
J Clin Microbiol. 2012 Mar;50(3):1023-6. doi: 10.1128/JCM.06248-11. Epub 2011 Dec 14.
4
Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.头孢泊肟酯:儿科患者细菌感染治疗应用综述
Paediatr Drugs. 2001;3(2):137-58. doi: 10.2165/00128072-200103020-00006.
5
Effects of nifedipine and diltiazem on pharmacokinetics of cefpodoxime following its oral administration.硝苯地平和地尔硫䓬对口服头孢泊肟药代动力学的影响。
Antimicrob Agents Chemother. 1996 Dec;40(12):2879-81. doi: 10.1128/AAC.40.12.2879.
6
Pharmacokinetics and ex vivo susceptibility of cefpodoxime proxetil in patients receiving continuous ambulatory peritoneal dialysis.接受持续性非卧床腹膜透析患者中头孢泊肟酯的药代动力学及体外药敏性
Antimicrob Agents Chemother. 1993 Dec;37(12):2650-5. doi: 10.1128/AAC.37.12.2650.
7
Pharmacokinetics of anti-infective agents in paediatric patients.抗感染药物在儿科患者中的药代动力学。
Clin Pharmacokinet. 1994 May;26(5):374-95. doi: 10.2165/00003088-199426050-00005.
8
Effect of food on absorption of cefpodoxime proxetil oral suspension in adults.食物对成人头孢泊肟酯口服混悬液吸收的影响。
Antimicrob Agents Chemother. 1995 Jan;39(1):273-5. doi: 10.1128/AAC.39.1.273.
9
Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢他美酯。其抗菌活性、药代动力学特性及治疗用途综述。
Drugs. 1993 Apr;45(4):589-621. doi: 10.2165/00003495-199345040-00009.
10
Clinical pharmacokinetics of newer cephalosporins.新型头孢菌素的临床药代动力学
Clin Pharmacokinet. 1995 May;28(5):361-84. doi: 10.2165/00003088-199528050-00003.